Treating High-Risk Patients with Dyslipidemia
Treating High-Risk Patients with Dyslipidemia
In this hour-long webinar, you will learn the latest in high-risk dyslipidemia, including:
- Differences and consistencies in the ACA/AHA and NLA guidelines
- Details regarding the use of PCSK9 Inhibitors in clinical practice, with a comparison of the two medications currently on the market
- A Review of the groundbreaking Fourier and Odyssey outcomes trials
- Case studies in Familial Hyperlipidemia that demonstrate the application of lipid-lowering therapies in practice
0.00